We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) announced today that it has completed the acquisition of Artesian Therapeutics, Inc., further to the letter of intent ("LOI") announced on August 29, 2005.
Brazil, the world's largest exporter of poultry, has announced that it is to spend BRL193mn (US$85.38mn) purchasing 9mn doses of Roche's anti-flu treatment, Tamiflu, in order to combat a possible avian flu pandemic.
India's Minister of Health and Welfare, Anbumani Ramadoss, is to travel to South Korea in order to strengthen co-operation between the two countries in a number of crucial health areas, including stem cell research.
Javelin Pharmaceuticals, Inc. announced today the UK Medicines and Healthcare products Regulatory Agency (MHRA) has accepted for review the Marketing Authorization Application (MAA) for Dyloject(TM) (injectable diclofenac) for the treatment of patients with postsurgical pain.
SHANGHAI Industrial United Holding Co, Ltd plans to invest 105 million Hong Kong dollars (US$13.5 million) with several Guangzhou Province partners to set up a new pharmaceutical company in Guangdong Province, according to its statement to the Hong Kong Stock Exchange yesterday.
Nektar Therapeutics (Nasdaq:NKTR) announced today that it has closed the acquisition of Aerogen, Inc. (OTCBB:AEGN) under the definitive merger agreement announced on August 15, 2005.
Amersin Life Science Corporation (OTCBB:AMLSE) announced today that it has reached a termination agreement and will be disposing of its interest in the Hubei Tongji Benda Ebei Pharmaceutical Co. Ltd. joint venture in the Hubei Province of China.
Discovery Laboratories, Inc. (Nasdaq:DSCO) announced today that its development and marketing partner in Southern Europe, Laboratorios del Dr. Esteve, S.A.